[1]
“Anaplastic lymphoma kinase gene rearrangement and non-small cell lung cancer management: a step forward in personalized therapy”, Clinics, vol. 68, no. 5, pp. 726–726, May 2013, doi: 10.1590/clin.v68i5.76854.